126 related articles for article (PubMed ID: 2716968)
1. Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz JC
Neuropharmacology; 1989 Feb; 28(2):117-22. PubMed ID: 2716968
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
Michael-Titus A; Preterre P; Giros B; Costentin J
J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
[TBL] [Abstract][Full Text] [Related]
3. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
Malin DH; Lake JR; Hamilton RF; Skolnick MH
Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
[TBL] [Abstract][Full Text] [Related]
4. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
Bousselmame R; Eustache M; Michael-Titus A; Costentin J
Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
[TBL] [Abstract][Full Text] [Related]
5. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
[TBL] [Abstract][Full Text] [Related]
6. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan.
Khallouk-Bousselmame R; Costentin J
Eur Neuropsychopharmacol; 1994 Jun; 4(2):137-43. PubMed ID: 7919943
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
8. Involvement of endogenous enkephalins in the mouse 'behavioral despair' test.
Natan LB; Chaillet P; Lecomte JM; Marçais H; Uchida G; Costentin J
Eur J Pharmacol; 1984 Jan; 97(3-4):301-4. PubMed ID: 6584312
[TBL] [Abstract][Full Text] [Related]
9. Pain control by endogenous enkephalins is mediated by mu opioid receptors.
Chaillet P; Coulaud A; Fournié-Zaluski MC; Gacel G; Roques BP; Costentin J
Life Sci; 1983; 33 Suppl 1():685-8. PubMed ID: 6319920
[TBL] [Abstract][Full Text] [Related]
10. Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord.
Dickenson AH; Sullivan AF; Fournie-Zaluski MC; Roques BP
Brain Res; 1987 Apr; 408(1-2):185-91. PubMed ID: 3474047
[TBL] [Abstract][Full Text] [Related]
11. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
Lambert DM; Mergen F; Poupaert JH; Dumont P
Eur J Pharmacol; 1993 Oct; 243(2):129-34. PubMed ID: 8276061
[TBL] [Abstract][Full Text] [Related]
12. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
13. Analgesia produced by immobilization stress and an enkephalinase inhibitor in amphibians.
Stevens CW; Sangha S; Ogg BG
Pharmacol Biochem Behav; 1995 Aug; 51(4):675-80. PubMed ID: 7675842
[TBL] [Abstract][Full Text] [Related]
14. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
Adjroud O
J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
[TBL] [Abstract][Full Text] [Related]
15. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
Rivière PJ; Buéno L
Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
[TBL] [Abstract][Full Text] [Related]
16. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin.
Llorens-Cortes C; Schwartz JC
Eur J Pharmacol; 1984 Sep; 104(3-4):369-74. PubMed ID: 6594244
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
Chipkin RE; Latranyi MB; Iorio LC
Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
[TBL] [Abstract][Full Text] [Related]
18. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
Nouel D; Dubuc I; Kitabgi P; Costentin J
Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor.
Chaillet P; Marçais-Collado H; Costentin J; Yi CC; De La Baume S; Schwartz JC
Eur J Pharmacol; 1983 Jan; 86(3-4):329-36. PubMed ID: 6572590
[TBL] [Abstract][Full Text] [Related]
20. Changes in levels of the tripeptide Tyr-Gly-Gly as an index of enkephalin release in the spinal cord: effects of noxious stimuli and parenterally-active peptidase inhibitors.
Llorens-Cortes C; Gros C; Schwartz JC; Clot AM; Le Bars D
Peptides; 1989; 10(3):609-14. PubMed ID: 2780419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
